drugset / Trial / NCT04882540
A Study to Evaluate the Pharmacokinetics and Safety of Brivaracetam in Healthy Chinese Subjects
NaSingle-groupOpen-labelBasic science
Summary
The purpose of the study is to assess the pharmacokinetics, safety, and tolerability of brivaracetam after a single dose and multiple doses in healthy adult Chinese Study Participants.
Timeline
- Start
- 2021-05-19
- Primary completion
- 2021-06-08
- Completion
- 2021-06-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brivaracetam | Small molecule | 100 mg | Oral |
Indications
No indication recorded.